Mesothelioma TreatmentMesothelioma Alerts
Report from Phase II Study of Vinflunine for Treating Malignant Pleural Mesothelioma
Vinflunine is showing encouraging signs for the treatment of Malignant Pleural Mesothelioma (MPM).
FDA Safety Changes: Pemetrexed Injection (Alimta, made by Eli Lilly and Company)
The US Food and Drug Administration (FDA) has approved drug safety labeling revisions to advise of the potential for dose-limiting myelosuppression in patients receiving treatment with pemetrexed injection.
Interferon Alpha May Help Treat Malignant Pleural Mesothelioma: Presented at STS
Interferon alpha maintenance therapy may provide substantial improvement in survival over existing therapies in patients with malignant pleural mesothelioma (MPM), according to findings presented here at the Society of Thoracic Surgeons (STS) 42nd Annual Meeting.
Test Could Spot Asbestos-Linked Lung Cancer (Mesothelioma)
There's hope for an early-detection test that could improve survival for people with a deadly cancer linked to asbestos exposure, researchers report...
Arthritis Drug Shows Promising Effects For Mesothelioma Victims
Researchers in Italy have discovered that studies involving Pfizer Inc.'s arthritis drug Celebrex have shown promising results in combating the effects of cancerous cell growth related to the asbestos-induced disease mesothelioma.
Implantable Device May Offer Better Pain Management
Patients with advanced cancer who used an implantable drug-delivery device to control their pain had better pain relief, fewer toxic side effects, and better survival than patients who received intensive medical pain management, researchers reported in the October 1, 2002, issue of the Journal of Clinical Oncology.
Chemotherapy Combination Promising For Mesothelioma
A new chemotherapy combination has shown "remarkable" activity against mesothelioma in an early study, British researchers reported on Tuesday.
